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1. Introduction 
The quality of pharmaceuticals cannot be compromised as these constitute a group of 
products ingested into the human and animal systems by routes such as oral, parenteral, 
topical etc. These groups of products therefore have direct bearings on our well being and 
there is therefore an absolute need to guarantee their quality, safety and efficacy. Drugs 
therefore have to be designed and produced such that when patients receive them for 
management of their ailments, they do not produce any adverse side reactions on such 
patients or their unborn babies. 
The sub-Saharan Africa countries market are flooded with fake and adulterated drugs to 
such an extent that only 30 % of drugs available in these countries can be said to be genuine 
in terms of contents and efficacy. The side effect of fake and adulterated drugs is so serious 
that therapeutically, if administered, can give rise to treatment failure which at times may be 
serious enough to result to death. Assurance of the quality, safety and efficacy of 
pharmaceutical products is a continuing concern of World Health Organization. It is now 
recognized that stability of active components of preparations poses serious problems for 
many manufactured products, especially those entering international commerce and/or 
distributed in territories with harsh climatic conditions. These problems may arise as a 
consequence of 
a. Improper storage (in heat, moisture, sunlight). This might lead to degradation or loss in 
potency. The manufacturer will always indicate the best possible storage conditions on 
the product, but it has been found that retailers and wholesalers do not have required 
facilities to achieve these conditions or some do not give regard to these warning 
consequently this leads to product quality deterioration before expiry dates. 
In most sub-saharan Africa countries, manufacturers, retailers, wholesalers and general public 
persistently flout most storage instructions and thereby jeopardize the quality of the product. 
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b. Poor quality assessment. Due to local sourcing of raw material in a developing nation, 
lack of current high-tech analytical instrument or even unavailability of certain reagents 
used in official procedure may force the quality control analyst to develop alternative 
methods. 
Despite efforts made around the world to ensure a supply of right quality and effective 
drugs, substandard, spurious and counterfeit products still compromise health care delivery 
in some countries especially in Sub-Saharan Africa.  
Every government allocates a substantial proportion of its total health budget to drugs. This 
proportion tends, to be greatest in developing countries, where it may exceed 40%.  
Without assurance that these drugs are relevant to priority health needs and that they meet 
acceptable standards of quality, safety and efficacy, any health service is evidently 
compromised. In Sub-Saharan Africa, drug manufacturing faces various challenges in 
assessment of quality of solid pharmaceuticals and intravenous fluid. 
The first challenge is the deterioration of solid pharmaceuticals during distribution and 
storage as a result of sunny and humid climate.. 
The second challenge is non-availability of equipments specified in official references books 
(British Pharmacopeaia and United States Pharmacopeaia) in monographs for analysis of 
drugs. The third challenge  is  insufficiency of personnel with adequate technical know-how 
to man the quality control unit of the pharmaceutical company. 
Intravenuos fluids, otherwise called infusions are fluids used in medical delivery by 
intravenous administration.  
The most challenging quality control aspect of infusion manufacturing are sterilty and 
pyrogen level determination of the final product. Most intravenuous fluid product failures 
in Nigeria involve sterility failures and high pyrogen contents. The challenges of quality 
control of infusion manufacturing in Nigeria is compounded by lack of infrastructures 
(epileptic electric power supply) and high cost of useful test kits for sterilty and pyrogen. 
There is challenge of finding a more affordable and reliable test materials (kit) for pyrogen 
test. Most companies use the rabbit test method for pyrogen tests which has limitations in 
false results, delayed decision making. Since rabbit test for pyrogen is done after the 
terminal sterilization of products, failed product cannot be re-processed. The Limulus 
Amebocyte Lysate (LAL) test kits are expensive and not affordable though reliable. Nigerian 
infusion manufacturers require a cheaper and locally sourced test kit for in-vitro 
determination of pyrogen in addition to good infrastuctures for smooth operation.  
It is therefore reasonable to assure that the analytical procedures involving the use of simple 
instruments will find greater application in Sub-Saharan Africa. Taking into consideration 
the aforementioned challenges, the main objectives of this paper is to carry out a review of 
degradation studies of common antibiotics in Sub-Saharan Africa by investigating the effect 
of heat, sunlight, moisture and U.V radiation on the potency of the drugs. The paper will 
also review some of the alternative analytical methods developed for assessment of quality 
of selected solid pharmaceuticals. A cheaper and locally sourced test kit for in-vitro 
determinations of pyrogen in intravenous fluids will be described. The chapter will also 
review some of the previous work done on this subject. 
2. Degradation of drugs 
Some of the drugs that are marketed in tropical countries are vulnerable subjected to 
degradation processes that can result into loss in the active component of these drugs. These 
problems may arise as a consequence of improper or inadequate storage and distribution of  
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the products which can lead to physical deterioration and chemical decomposition resulting 
in reduced bioactivity, formation of toxic degradation products or the formation of an 
unstable product especially under tropical conditions of high ambient temperature and 
humidity. Many pharmaceutical substances are known to deteriorate during distribution 
and storage particularly in hot, sunny and humid climate. Tropical and subtropical climatic 
conditions are therefore expected to pose serious problems with respect to stability of drug. 
Many drugs are thermosensitive, when they are exposed to high temperature, degradation 
tends to occur.Many workers have investigated the effect of heat on the degradation rate 
profile of many pharmaceuticals. 
In 1982, Kabela studied the influence of temperature on the stability of solid tetracycline 
HC1 measured by High Performance Liquid Chromatography in pure drug and capsules. 
The tetracycline hydrochloride were stored for about two years at temperature of 37°C, 
50°C, and 70°C. It was found that at 37°C and 50°C, no decomposition was observed for 
tetracycline nor for its related substance. At 70°C, a distinct decrease in tetracycline HC1 
was observed as well as a small increase in degradation products (Anhydrotetracyclinavaie 
HC1, 4-epitetracycline HC1 and 4-epianhydrotetracycline HC1). The degradation products 
are shown in figure 1. 
 
OOHO
OH
CONH2
H
OH O
Me
OH O
CONH2
OH
OH
H
H N(CH3)2
OH O
Me
OH
OH
H
O
CONH2
OH
H
N(CH3)2OH
CH3 N(CH3)2
4-epitetracycline
4-epianhydrotetracycline                                          Anhydrotetracycline
 
Fig. 1. Degradation products of tetracycline 
Another work on influence of temperature on drugs was reported by Matsui et al., (1978) . It 
was observed that phenylbutazone (figure 3) formulations showed no evidence of chemical 
instability when stored at ambient temperature of 37°C. At temperature above 37°C 
measurable chemical degradation occurred with several formulations showing more than 
50% degradation.  
Even at temperature below 37°C , degradation can take place as shown by work carried out 
by Kaplan et al, 1976. They reported that Amikacin exposed to 25°C for 24 months showed  
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an average of 3.9% degradation. But when the drugs were subjected to 56°C for 4 month an 
average of 7.2% degradation was observed. Owoyale and Elmarkby, (1989) found out that 
proguanil (Figure 4) which appeared not to undergo photochemical reaction was thermally 
degraded when subjected to heat at 45°C. The same drug when stored at room temperature 
of 25°C for six years was found not to undergo any decomposition. 
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Fig. 2. Structure of Phenylbutazone 
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Proguanil  
Fig. 3. Structure of Proguanil  
Low temperature can sometimes have a negative effect on the stability of some drugs, for 
instance sulfacetamide sodium (Figure 3) in aqueous medium may be recystallized if stored 
at low temperature. 
 
H2N
S
N
Na
CH3
O
OO
Sulphacetamide Sodium  
Fig. 4. Structure of Sulfacetamide Sodium 
Many drugs have been discovered to be photosensitive, hence they undergo photochemical 
reactions when exposed to sunlight, due to absorption of U.V light (wavelength of 190 - 
320mn). It is therefore not surprising to find many pharmaceutical preparation being 
destroyed or degraded when exposed to sunlight. 
Fadiran and Grudzinski, (1987) studied photostability of chloramphenicol using TLC to 
detect the number of degradation products. It was shown that chloramphenicol in solid 
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crystalline state (pure drug) and capsule on exposure to U.V light and sunlight developed a 
yellow colour, the intensity of which increased with increasing exposure time. During 
photolysis of chloramphenicol, the Beta-bond to the aromatic ring undergoes cleavage to 
yield one aromatic and one alkyl radical. Irradiation of drugs in solution produces a reaction 
that is faster than in solid state. Earlier worker preferred to study degradation of drugs in 
solution. 
Chloramphenicol was degraded by light in 0.25% w/v aqueous solution and the solution 
became yellow and acid to form 2-amino-1 -(4-nitrophenyl) propane-1, 3-diol. and 
dichloroacetic Acid. (Shih,1971). Similarly, Hvalka, (1989) reported that the potency of 
tetracycline HC1 reduced to 50% when the solution was irradiated with U.V. light for 3 
hours. The Degradation products are 4-epitetracycline, Anhydrotetracycline and 4-
epianhydrotetracycline. 
Drugs which contain multiple unsaturation are particularly prone to photolysis. Drugs with 
more double bonds are more susceptible to degradation. This assumption was proved by 
Hamlin et al. (1960), they investigated the photolytic degradation of alcoholic solution of 
hydrocortisone, prednisolone, and methylprednisolone exposed to Ordinary Fluorescent 
light. It was discovered that the degradation follows 1st order kinetics and that prednisolone 
and methylprednisolone showed the same rate of degradation, whereas hydrocortisone 
degrades 1/7th the rate of the two steroids. Hence the two double bonds present in 
prednisolone and methylprednisolone make these steroids more susceptible to light 
catalyzed degradation than the one double bond in the ring of hydrocortisone. 
Solid pure drugs with ester, amide linkages deteriorate with moisture via hydrolysis 
pathways. The effect of moisture on degradation of drugs, are many, when deposited on 
drugs, especially the solid dosage forms, it provides a suitable medium for micro-organism 
to thrive which may eventually lead to biological degradation of the drugs. Moisture may 
also cause some physical changes such as swelling, dissolution, cracking and adhesion of 
coated tablets. Ordinarily, one expects hydrolysis to occur frequently in drugs in aqueous 
solution and suspension. 
Leeson and Mattocks (1958) reported that a thin layer of moisture deposited on aspirin was 
all it needed for hydrolytic degradation to commence.  
There is no restriction to the use of additives and excipient but they should be chosen in a 
way so as not to affect the stability of the drugs. Incompatibilities of active ingredient with 
additives can lead to degradation. Kornblum and Zoglio, (1967) studied the potency 
degradation of Aspirin suspension with lubricant-namely, Aluminum stearate, magnesium 
stearate, calcium stearate. It was found out that the extent of degradation was more with 
magnesium stearate.  
From the review of the previous works done on degradation of drugs, it can be observed 
that few works have been reported in degradation of antibiotics, especially in solid state. 
The few reports that are available are not comprehensive enough especially exposure of the 
drugs to environmental conditions. Hence there is need to investigate and carry out 
extensive studies on the degradation of drugs.  
Antibiotics like any other drugs show loss in potency when subjected to some 
environmental conditions. 
In continuation of an effort on stability studies of drug, effects of moisture, sunlight, heat 
and UV radiation on the potency of some antibiotics (Ampicillin, Tetracycline and 
Chloramphenicol) were investigated by our research group (Adediran and Tella, 2000; 
Adediran et al, 2003; Tella et al, 2008). The pure drug of antibiotics and capsules were 
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exposed to moisture, sunlight, temperature (37°C), (70°C) and UV (254nm) for 60 days. 
Percentage potency or Percentage residual amount of active ingredient were determined 
before and after exposure. 
The three drugs showed evidence of stability with no loss of potency at 37°C, but exhibited 
loss in potency when exposed to moisture and heat at 70°C. 
Exposure of the three drugs to sunlight and UV resulted in loss of potency except Ampicilin 
which showed loss in potency only at UV radiation. 
 
Peak (cm-1) Assignments 
3789 Free OH 
3475 N-H (str) 
2920 C-H (Str) 
1895 C=O (str) 
1684 C=C aromatic System 
1352, 1527  NO2 vibration 
1569 C-N (str) 
1069 C-O (str) 
978 O-H (def) 
701 Presence of free adjacent protons in aromatic 
Table 1. Infrared spectrum of unirradiated Chloramphenicol pure drug and its assignment 
 
Peak (cm-1) Assignment  
3475 N-H (str) 
1647 C=O (str) or C=C (str) 
1521 presence of NO2 vibration 
1418 C-H (def) in methyl) 
1069, 1105 C-O (str) 
972 OH (def) 
701, 815 Presence of hydrogen or Proton in aromatic 
Table 2. Infrared spectrum of sunlight irradiated Chloramphenicol pure drug 
The infrared spectral assignments of samples of the Chloramphenicol exposed to sunlight 
and unexposed chloramphenicol are shown in tables 1 and 2 
Peaks such as 3789 cm-1 due to free OH, 2920cm-1 for C-H (str) in unexposed pure drug 
disappeared in the drug exposed to sunlight. This is in agreement with the finding of 
Fadiran and Grudzinki(1987) who reported that β–bond to aromatic ring present in 
Chloramphenicol molecule in solid state undergoes cleavage to form one aromatic and one 
alkyl radical when the drug was exposed to sunlight.  
Also 1894cm-1 due to C=O (str), 978cm-1 due to O-H (def) in pure drug shifted to 1647cm-1 
and 972cm-1 respectively in exposed drug. There is one C-O (str) peak at 1069cm-1 in pure 
drug whereas there are two in the exposed drug, one at 1069cm-1 and another 1105cm-1. All 
these changes arise from peak destruction and spectra shift are indications of drug 
degradation. 
Infra red spectroscopic analyses were carried out on ampicillin and Tetracycline before and 
after exposure to heat and moisture (Tables 3, 4 , 5 and 6). Ampicillin drug was exposed to 
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heat at 70°C and moisture for 60 days. Ampicillin pure drug exposed to temperature 70°C 
exhibited loss in potency and degradation as evidenced by disappearance of absorption 
band at 1785cm-1 of the C=O (Str) in the Beta-lactam ring. This led to the appearance of new 
band at 2932cm-1 due to C-H (str) and 2510cm-1 due to S-H (str) and C=N (str) at 1563cm-1 in 
Ampicillin exposed to 70°C to form pencillenic acid as shown in Figure 5. 
 
Peak (cm-1) Assignment 
3700 OH in carboxylic acid 
3442 Free N-H (str) 
1782 C=O (str) in β–lactam ring  
1697 C=O (str) in the amide 
1266 C-N (def) 
1168 C-O (str) 
651, 700,931 Presence of free adjacent protons in aromatics or C-S (str). 
Table 3. Infrared spectrum of ampicillin pure drug (unexposed) and its assignment 
 
Peak (cm-1) Assignment 
3700 OH in carboxylic acid 
3451 Free N-H (str) 
2931 C-H (str) 
2510 S-H (str) 
1660 C=O or C=C (str) 
1576 C=N (str) 
1508 Presence of aromatic system  
1400 C-H deformation in CH3 or CH2 
1243 C-O (str) 
701 Presence of free adjacent protons in aromatics.  
Table 4. Infra-red spectrum of ampicillin pure drug exposed to 70°C (assignments) 
 
Peak (cm_1) Assignments 
3500 N-H (str) 
2360 H-X (str) in salt of hydrohalides) 
1715 C=O (str)  
1636 C=O/CO-NH2 (str) 
1500, 1526 C=C Stretching in Aromatic system. 
1236, 1183 Presence of C-O/C-N (str) 
Table 5. Infrared spectrum of tetracycline pure drug unexposed (assignments) 
It can be observed from Figure 5 that the peaks due to 1715cm-1 and one (2360) due to H-X 
(str), in unexposed drug disappeared in spectrum of exposed drug. Also, new peaks at 
2926cm-1 due C-H (str) and 3700cm-1 due to free OH appeared in the exposed drug, which is 
an indication that hydrolysis of tetracycline may have taken place.  
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Fig. 5. Rearrangement of Ampicillin after exposure to heat 
 
Peak (cm-1) Assignments 
3700 Free O-H 
3500 N-H (str)/ OH in carboxylic acid. 
2926 C-H (str)in Aromatic system 
1623 C=O (str) 
1521 C=O in aromatic system 
1038, 1128, 1261 C-O/C-N (str) 
Table 6. Infra-red spectrum of tetracycline capsule exposed to moisture 
The infrared spectra of all the three drugs showed evidence of degradation when they are 
exposed to different environmental conditions.  
3. Development of alternative analytical procedure 
The awareness of populace as regards drug toxicity and effectiveness in relation to drug 
quality, requires stricter control of qualitative and quantitative nature of governmental 
agencies. It is however not possible to enforce a quality standard when there is no analytical 
method to determine the level of compliance with such standard. 
New analytical procedure development is required due to advancement of pharmaceutical 
practice but problems peculiar to an environment may bring about adaptation of even old 
methods. 
In any case, such new method has to be checked to be at least of equal performance, if not 
superior, to an already accepted official compendia method. 
The first scientist to develop analytical method for the assay of penicillin was Alicino24 in 
1946. He reported the first general iodometric method for the assay of most penicillin. He 
discovered that most chemical methods of assay for the benzyl penicillin salts depend upon 
hydrolytic cleavage of the Beta-lactam ring to give penicilloic Acid. The cleavage can be 
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brought about either by alkali or by the enzyme penicillinase. If the cleavage is brought by 
penicillase in a previously neutral and unbuffered solution the resulting acid may be titrated 
with alkali to give a measure of the penicillin present. Alternatively, most commonly, the 
liberated penicilloic acid is determined through the ability to take up iodine, a property not 
possessed by the parent molecule. This method has undergone various modifications and 
revisions from time to time.  
The modification of Alicino was done by Beckett and Stenlake (1976) using benzyl penicillin 
for the modification. After primary hydrolysis with sodium hydroxide solution to convert 
the antibiotics to the corresponding penicilloic acid, treatment with acid yield D-penicillamine 
(and benzylpenillic Acid) which is oxidized almost quantitatively by iodine to the 
corresponding disulphide, excess iodine is back-titrated with 0.02M sodium thiosulfate 
solution. The equation of reaction is shown figure 6. 
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H
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CH3
CH3
H
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(H3C)2C CH.COOH
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Fig. 6. Back -titration of Ampicillin by iodiometry  
Benzyl penicillin sodium is standardized against a chemical reference substance of known 
potency. 
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The above method has two principal advantages over spectrophotometric method. First, it 
has a high degree specificity since non-penicillin impurities are to a large extent allowed for 
in the blank determination and secondly the relatively large iodine absorption makes the 
method highly sensitive. 
Apart from the titrimetric methods of assay reported above, an attempt was made to assay 
penicillin by spectrophotornetric method. Beckett and Stenlake,1976 described the 
spectrophotometric method by the use of imidazole mercury reagent. Mercuric chloride is 
known to attack the sulphur atom of the penicillin leading to a rearrangement involving 
penicillin side chain. The rearrangement is catalyzed by imidazole. The product III formed is 
a penicillenic acid mercuric mercaptide which absorbs between 325 - 345nm. The equation 
of reaction is shown in figure 7.  
By using a reference and test samples, the absorbance given by the penicillenic acid mercuric 
mercaptide formed from a known weight of the reference is compared with that of the test. 
From the comparison of the absorbance given by a reference as compared to that of the test 
sample, the actual penicillin content can be computed. The method is official in British 
Pharmacopoeia (1993) and India Pharmacopoeia (1985) for assay of cloxacillin, fluocloxacilin 
and ampicillin. 
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Fig. 7. Spectrophotometric analysis of Penicillin 
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The second instrumental method for the assay of penicillin was reported by Bungaard and 
Larsen,(1983) . They made use of sorbitol reagent in the analysis of Ampicillin, Amoxycillin 
and Cyclacillin. Sorbitol reagent is an hydroxyl compound, it was used to form a penicilloyl 
ester intermediate II, which rearranges to a corresponding piperizinedione derivative III. 
Treatment of the derivative with 1M NaOH gives a highly absorbing product with 
absorption maximum at 322nm. The equation of reaction is shown in figure 8. 
The reaction is  catalysed by the reaction in catalyzed by metal ions. Zinc ions were found to 
be most effective catalyst. Aminopenicillin such as Ampicillin, Amoxycillin and Cyclacillin 
can be determined quantitatively by this method.  
Most official books such as, British Pharmacopoeia (1993), United states pharmacopoeia 
(1990) and International Pharmacopoeia (1979) described the analysis of tetracycline HCl 
using microbiological, non-aqueous and spectrophotometric methods. 
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Fig. 8. Spectrophotometric analysis of Ampicillin 
As far back as 1956, Woolford and Chiccarelli proposed first spectrophotometric method of 
analysis of tetracylines, which is based on the formation of yellow colour with an absorption 
maximum at 320nm when tetracycline HCl is dissolved in 0.2M sodium hydroxide. The 
disadvantage of the method is that it is not applicable to oxytetracycline and chlortetracycline. 
Effort was made to develop analytical method that will be applicable to all three common 
tetracyclines. Monastero et al. (1951) were able to come up with a method which applied to 
all three tetracyclines. The method involves mixing of dilute hydrochloric acid solution with 
ferric chloride solution to form orange-brown colour which gives maximum absorption at 
490nm. This method has been adopted as official method for the analysis of oxytetracylines 
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in Indian Pharmacopoeia., 1985). Phosphates, fluorides, thiocyanates and other substances 
that combine with iron (III) interfere and therefore if present must be removed before 
carrying out determination. 
Yokohoma and Chatten, (1958) reported non-aqueous method for tetracycline. It was shown 
that tetracycline hydrochloride may be titrated non-aqueously with perchloric acid in 
dioxan by addition of mercuric acetate. Tetracycline which is halide salt is treated with 
mercuric acetate to precipitate the halide ion as undissociated mercuric (II) halide and form 
the acetate salts which reacts quantitatively with perchloric acid thus preventing 
interferences of halogen.The methods are not selective for separation and determination of 
tetracycline degradation products in tetracycline HC1 powder and capsules. In order to find 
solution to this problem, Omer et al, (1958) used thin layer chromatography for the 
separation and semiquantitative determination of tetracycline degradation products in 
tetracycline Hydrochloride powders and capsules. 
It failed in an attempt to fully quantify the degradation products and content of residual 
drug. This led to the development of more sensitive technique that quantified and 
differentiate between the degradation products and intact molecule of drug by Kabela in 
1982 using HPLC. He was able to determine the amount of degradation products  
(4-epianhydrotetracycline, Anhydrotetracyline and 4 - epitetracycline) present in tetracycline 
Hydrochloride. 
British Pharmacopoeia (1980) described a spectrophotornetric method to measure the total 
absorbance of degradation products in tetracycline hydrochloride. The absorbance limit set 
by the British Pharmacopoeia (1980) is twice that which has been set for tetracycline 
hydrochloride capsules and powder. The samples of tetracycline hydrochloride capsules 
and standard were examined at 430nm. 
Some official books British Pharmacopoeia (1993), International Pharmacopoeia (1979) 
described spectrophotometric method for the analysis of chloramphenicol, by taking the 
absorbance of chloramphenicol solution at 278nm. 
Chloramphenicol eye drops, ear - drops and capsules can also be determined by colorimetric 
method based upon reduction of the nitro group with zinc, stannous chloride or better 
sodium dithionate followed by diazotization and coupling with N-(-1-naphthyl) ethylene 
diamine. 
Most assay methods for the drug are based upon its functional groups and will not 
differentiate between chloramphenicol and its degradation products. It is known that 
chloramphenicol loses its antibiotic activity by the hydrolysis of the amide bond to give  
2-amino-1-(4-nitrophenyl) propane-1,3-diol. 
This latter compound commonly occur in pharmaceutical preparation and because of the 
structural similarity of the chloramphenicol and 2-amino-1-(4-nitrophenyl) propane-1,3-diol, 
the specific determination of chloramphenicol by spectrophotometer is unsuitable. The 
absorption is due principally to the nitrophenyl functional group and hence degraded 
chloramphenicol will also absorb at 278nm. 
To ensure freedom from interference due to degradation of the chloramphenicol molecule, 
the chromatographic separation procedure is suggested preliminary to all analyses. Higuchi 
et al. (1954) developed a simple partition chromatographic procedure which separated 
degradation products of chloramphenicol from chloramphenicol molecule. Many other 
interferences are also removed, since partition method is extremely sensitive to differences 
in molecular structure. The eluate obtained containing chloramphenicol is then determined 
by spectrophotometer at 272nm. 
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Piergiorgio, 1979 proposed the application of simplified TLC method for the simultaneous 
determination of chloramphenicol and 2-amino-1-(4-nitrophenyl) propane-1,3-diol. The 
principle of this method consists of spotting the solution on a Thin layer chromatography 
plate together with standard solution and developing the plate with an ethyl acetate-formic 
Acid - water (10:2:8, upper plate) solvent. The intensities of the various spots are then 
measured by a densitometer and the peak height of the standards are used to calculate the 
concentration of chloramphenicol and 2-amino-1-(4-nitrophenyl) propane-1,3-diol. in 
unknown sample. This procedure is too laborious, not precise and tedious. 
A more rapid, precise and accurate method was developed by Belle and Young,(1979). The 
method was based on the use of High performance Liquid chromatography for determination 
of chloramphenicol and 2-amino-1-(4-nitrophenyl) propane-1,3-diol. in Pharmaceutical 
formulations. 
The method possesses a distinct advantage because the method does not require extraction 
nor derivatization for the determination of both chloramphenicol and 2-amino-1-(4- 
nitrophenyl) propane-1,3-diol. in capsule, ophthalmic solution and ophthalmic ointment 
formulation. 
The solvent extraction method has been described in British Pharmacopoeia (1980) for the 
determination of 2-amino-1-(4-nitrophenyl) propane-1,3-diol. Albendazole is a broad 
anthelmintic (figure 9). It is used for the treatment of threadworm, hookworm and tapeworm.  
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Fig. 9. Structure of Albendazole 
Extensive literature survey reveals that the estimation of Albendazole in dosage and 
suspension forms are not available in pharmacopoeia and therefore require much 
investigation. The drug is readily available in Nigeria market in tablet, bolus (veterinary 
preparartion) and suspensions. The need to come up with a simple and sensitive method of 
analysis for the estimation of drug in pharmaceutical preparations therefore arises. 
Spectrophotometric method for the estimation of Albendazole in both solid and liquid 
preparation was developed (Tella et al,2010). Treatment of Albendazole with methanolic-
glacial acetic acid gives a highly absorbing product with absorption maximum at 235nm. 
Beer law was obeyed in the concentration range 2.5-20μg/ml 
 
Brands Forms Label claim(mg,mg/ml) Found(mg,mg/ml) 
A Tablet 200 194.24±0.553 
B Bolus 250 243.07± 0.512 
C Bolus 500  497.6 ± 0.272 
D Suspension 25  25.11± 0.386 
E Suspension 25  24.60± 0.246 
Table 7. Results of assay of Albendazole of different brands in solid dosage and suspension 
form 
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The results obtained from analysis of different brands of Albendazole tablets, bolus and 
suspension were in good agreement with the the label claims as shown in Table 7.  
The little difference might be due to batch variation of medicaments in tablets, bolus and 
suspension, instrumental errors or degradation of active ingredients with time. The method 
could be considered for the determination of Albendazole in quality control laboratories.  
Another alternative method developed for estimation of sulphadimidine in tablets is simple 
and rapid titrimetric method (Back titration). Sulphadimidine is bacteriostatic. It is an 
antibacterial (intestinal drug) (Figure 10). 
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Fig. 10. Structure of Sulphadimidine 
The drug is presented in tablets, injections, suspension and veterinary tablets. 
Official methods for the analysis of the drug in pharmaceutical preparations are the 
potentiometric and Nitrite Titrations. The end point of Nitrite titration method is detected 
either electrometrically or by using an external indicator. By streaking a few drops of the 
titrated solution upon starch iodide paper or paste, a dark blue colour is obtained. Excess 
nitrous acid oxidizes the iodide in the indicator to give iodine which gives blue color with 
starch. The disadvantage of this method is that the visual end point with external starch 
iodide indicator may seem somewhat indefinite and difficult to determine. The great 
disadvantage of the electrometric end point and the potentiometric titration is lack of 
specificity. They also require expensive equipments, some level of expertise and are time –
consuming. The average time to complete the reaction requires about 2 hours. However , the 
proposed method can be completed within 20minutes (Tella et al, 2010). The reagents are 
also available. 
The procedure is described as follows: Standard drug solution was prepared by dissolving 
250mg of Sulphadimidine B. P. in 30ml ethanol (96%) in a 250ml conical flask. 40ml of 0.1M 
sodium hydroxide solution was then added. 
The content of the flask was mixed well and warmed on water bath for 5 minutes. It was 
allowed to cool. The excess alkali was then titrated with standardized 0.1M hydrochloric 
acid using 3 drops of Phenolphthalein solution as indicator. The operation was repeated 
without the substance being examined. 
The difference between the titrations represents the amount of 0.1M sodium hydroxide 
required by the Sulphadimidine. Each milliliter of 0.1M sodium hydroxide is equivalent to 
0.02783g of C12H14N4 O25S (Sulphadimidine) 
Equation of the reaction is shown below (Figure 11) 
The result obtained by the proposed and reported methods for the weighed Sulphadimidine 
B. P. and commercial samples of Sulphadimidine tablets are given in Table 8. The 
percentage recoveries show that the proposed method can be adopted for routine analysis of 
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Sulphadimidine tablets. The results obtained by the proposed method were in good 
agreement with the labeled amount.  
 
H2N
S
N
H
NN
Me
OO
Me
H2N
S
OH
OO
N N
CH3H3C
NH2
Sulphadimidine
Alkaline hydrolysis
Sulphanilic acid  
Fig. 11. Titrimetric analysis of Sulphadimidine 
 
Titrimetric method (back titration) Reported method (nitrite titration) 
Labeled 
Amount 
(mg) 
Quantity 
Found 
(mg) 
Recovery 
(%) 
Standard 
Deviation 
Recovery 
(mg) 
Recovery 
(%) 
Standard 
Deviation 
500 498.98 99.80 ± 0.06 496.24 99.25 ± 0.07 
500 495.43 99.09 ± 0.09 490.83 98.17 ± 0.05 
500 493.43 98.69 ± 0.10 500.00 100.00 ± 0.06 
500 500.18 100.04 ± 0.08 494.56 98.91 ± 0.03 
500 499.24 99.85 ± 0.03 492.48 98.50 ± 0.02 
(Average of 10 determinations) 
Table 8. Average recoveries from the various commercial samples of Sulphadimidine 
tablets. 
4. Adsorption of drugs on pharmaceutical exicipents 
It has been established that the presence of adsorbent, such as activated charcoal interferes 
with the drug adsorption process resulting in a decrease bioavailability of some drugs. The 
interference in the systematic availability of drug is brought about by its adsorption on the 
activated surface of the solid adsorbent, thus preventing the adsorbed fraction of the drug 
from permeating through the gastro- intestinal mucosa into the blood stream. 
Some of these drugs may be lost when adsorbent are administered concomitantly with the 
drugs. 
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Furthermore, in sub-Saharan Africa, the abuse of various drugs has increased considerably 
in the last decades. Many drugs used in treatment of tropical diseases have been implicated 
in various intentional and accidental poisoning. Adsorption and interaction of 
chlorapheneramine and chloroquine phosphate on pharmaceutical materials like magnesium 
trisilicate, Activated charcoal, magnesium carbonate and magnesium stearate was investigated 
by our research team. Freudlich Adsorption isotherm was adopted to evaluate adsorption 
capacity of each adsorbent on chloroquine phosphate. The freudlich parameter kf which is 
adsorption capacity obtained for the adsorbents are 0.053, 0.145, 0.131 and 0.173mg/g for 
magnesium carbonate, magnesium stearate, magnesium trisilicate and activated charcoal 
respectively showed that these adsorbents have ability to adsorb or remove chloroquine 
phosphate molecules from solution at PH 5.0 (Adediran et al,2006) 
The extent of adsorption of chloroquine phosphate by the adsorbents followed the sequence; 
Activated charcoal > magnesium trisilicate > magnesium stearate > magnesium carbonate. 
Differences in surface characteristics and chemical structure of adsorbent may be 
responsible for the trend observed above.  
Activated charcoal has the highest adsorption capacity which may be due to its organic 
nature and presence of phenolics and carboxyl moieties. 
Magnesium trisilicate (Antacid) adsorbed Chloroquine better than magnesium stearate, 
because there is chemisorptions interaction between the negative charge of the adsorbent 
and positive charge of the drug molecule. The presence of small amount of oleate molecules 
in magnesium stearate enhances adsorption over magnesium carbonate. The findings are in 
agreement with the work of Mcginity and Lach, 1976, Cooney 1977 and Guay et al, 1984. 
Our investigation revealed that concurrent administration of these pharmaceutical adsorbents 
and chloroquine drug might interfere with chloroquine adsorption. Furthermore, these 
adsorbents can serve as alternative antidote for chloroquine poisoning. We also investigated 
the in-vitro absorption of chlor pheniramine maleate on these adsorbents. Chlorapheniramine 
maleate is an antihistamine which reliefs red, itchy and watery running nose. The study was 
carried out at PH = 5.0 and 37°C using Batch method. Freudlich parameters were determined 
for each adsorbents as shown in Table 9). The freudlich parameter (kf) are 4.68, 4.47, 4.80 
and 1.91 for activated charcoal, magnesium trisilicate, magnesium stearate and talcum 
powder (Tella and Owalude, 2007). The adsorbents have ability to adsorb or remove 
chlorapheniramine maleate from solution at 3.0 – 5.0mg/l adsorbate. The drug was mostly 
adsorbed by the activated charcoal and least absorbed by talcum powder.  
We concluded that concurrent administration of these pharmaceutical adsorbents and 
chlorapheniramine maleate might induce interference between them thereby affecting the 
bioavailability of the drug to the system. There is possibility of using these adsorbents as 
antidote in case of Chlorapheniramine maleate over dose or poisoning.  
 
Absorption 1/n Kg x 10-3mg/g 
Activated charcoal 0.65 4.68 
Mg Si O3. 0.66 4.47 
Magnesium stearate  0.77 3.80 
Talcum powder 0.99 1.91 
Table 9. Freudlich adsorption parameters of CPM on Adsorbents 
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5. Intravenous fluids 
An intravenous fluid is a sterile, pyrogen-free, particle-free solution used for therapeutic 
purposes by infusion through the veins.  
Intravenous fluids (I.V. Fluids) are solutions sometimes containing electrolytes such as 
sodium chloride, potassium chloride and calcium chloride; energy-giving compounds like 
dextrose and other ion-balancing solutions such as compound of sodium lactate (Hartman’s 
and Ringer Lactate Solutions).  
Examples of I.V. Fluids are: 
- Normal Saline (0.9%w/v Sodium Chloride in water)  
- Dextrose 5% w/v Saline (containing g/Litre Sodium Chloride and 50g/Litre dextrose 
anhydrous). 
- Dextrose 5% w/v (containing 50g/litre dextrose anhydrous). 
- Dextrose 4.3% w/v + 0.18% Saline (containing 43g/Litre dextrose anhydrous + 18g/Litre 
Sodium Chloride).  
- Dextrose 50% w/v Solution (containing 50g/100ml Dextrose anhydrous)  
- Dextrose 10% w/v Solution (containing 100g/Litre dextrose anhydrous).  
- Metronidazole Injection – 0.5% w/v (containing 0.5g metronidazole / 100ml). 
- Hartman’s Solution  
- Darrow’s Solution – Full strength and ½ Strength. 
- Plasma expanders such as 4% polyvinyl pyrollidone (povidone k30 – in water).  
5.1 Uses / functions of I.V. Fluids 
I.V. Fluids are normally infused into ambulatory patients - usually very weak, unable to eat 
or drink, or totally of unconscious, in shock or acetate coma. I.V. Fluids are therefore, a life 
saving device for critical care of patients. I.V. Fluids have constituents that are used 
selectively to correct certain imbalances in the body fluids of patients and to supply, the 
required energy by directly infusing the metabolisable carbohydrate monomer – D-glucose 
in the various concentrations, depending on the specific requirement of the patient.  
I.V. Fluids essentially do the following: 
a. Rehydrate patients  
b. Replace lost ions such as sodium ion, chloride ion from normal saline (0.9% sodium 
chloride I.V. Solution). potassium, calcium and chloride ions from Darrow’s solutions 
full strength and half strength. Calcium, sodium, potassium and chloride ions. Lactates 
from ringers (Hartman’s solution).  
c. Increase total blood volume in short time (in cases of server blood loss) for accident 
victims. Plasma expanders such as Isoplasma (4%w/v polyvinyl pyrollidone in 0.78%w/v 
saline) he as to replace blood volume without affecting ion – balance in the patients.  
d. Supply energy in the form of dextrose anhydrous. All dextrose containing I.V. Solutions 
are energy sources for ambulatory patients. The specific need of each patient must be 
ascertained to determine what to give him/her.  
e. Lactate – containing products help to correct low pH in the blood by metabolizing 
lactate to release bicarbonate ions (HCO3-) into the blood and hence neutralize the 
excess hydrogen ions in the blood.  
f. Amino Acid, fatty acids, mineral and vitamin nutritional supplements are nowadays 
available as intravenous infusions  
Intravenous fluids belong to a group of pharmaceuticals called parenterals. i.e. medications 
that are administered by other routes than through the intestinal absorption into the blood. 
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Other parenteral preparations include irrigation solutions, Peritoneal Dialysis Solution, 
Heamodialysis Concentrates e.t.c.   
5.2 Quality of intravenous fluids 
Intravenous fluids are administered directly into the blood stream through the veins. The 
veins empty it through the heart, which pumps it round the body. Hence it is very easy to 
deliver proper medication and hence therapy through I.V. Fluids or poison contaminations 
or germs through the same route if the I.V. Fluid is not of the right quality. I.V. Fluids must 
be sterile, pyrogen-free, particle – free and contain the right quantity of constituents as per 
the labelled amount of the product. The acceptable limit of the constituent throughout the 
shelf life of the product must remain between 95% and 105% of the label claim and in some 
case 90% to 110% at most.  
5.3 Critical quality of I.V. Fluids 
Sterility 
I.V. Fluids must be free of viable organisms be it bacteria, fungi, algae or any microbe. If the 
I.V Fluid is not sterile after preparation it may remain clear for a while and later turn cloudy 
or show massive macroscopic growth. A seemingly clean pouch may actually not be sterile. 
But such contaminated pouch will later turn cloudy. A non-sterile material when infused 
poses dangers of sepsis (heavy blood contamination by germs) to the patient and resultant 
adverse reaction and death. Therefore, sterility is a critical quality of I.V. Fluids.  
Pyrogen – Free status 
Pyrogen simply means a substance which when injected elicits adverse reactions such as 
fever, rigours, palpitations and restlessness in the patients that receive it. Pyrogens are 
endotoxin produced by Gram negative bacteria. The bacteria may be killed (destroyed) by 
sterilization but the endotoxin present in them is released into the fluid medium. The 
pyrogenic solution when injected cause adverse reactions in the patient. Therefore, 
pyrogen–free status is a critical, acceptable quality of I.V. Fluids. I.V. Fluids must be free of 
solid or suspended particles I.V. Fluids packaged must remain intact. A broken package that 
lets in air becomes contaminated and loses its sterile status.  
Bacterial endotoxin as impurity in sterile pharmaceuticals 
Gram negative bacteria produce bacterial endotoxin. They are made up of the 
lipopolysaccharide (LPS) that constitute the cell walls of Gram negative bacteria. They are 
called endotoxin because they are not released to the outside environment of the bacteria 
until the cells die. They are released after cells disruption. Bacterial endotoxin abounds 
everywhere. The Gram negative bacteria exist in particulate matter, in air, water and soil 
(Schaumann, et al., 2008).  
Endotoxin is detectable in ambient aerosols and it is an important component of tobacco 
smoke. (Larson et al., 2004) It has been reported that early life exposure to endotoxin protects 
against the development of allergies. (Braun-Farhlander, et al., 2002). Exposure to household 
endotoxin is a significant risk factor for increased asthma prevalence in adults. Higher levels 
of exposure to endotoxin were significantly associated with asthma diagnosis (Schaumann, 
et al., 2008). It is a known fact that in asthma patients’ inhalation of endotoxin causes a 
significant decrease in lung functions with enhanced airway hyperactivity (AHR). 
(Schaumann et al,. 2008). Endotoxin is also an impurity in sterile pharmaceuticals especially 
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Large Volume Parenterals (LVPs) and it has to be tested for in the products meant for 
intravenous administration (Radhakrishnan, 2010). 
6. Current methods and manufacturers (users) experience 
The test for pyrogens in LVPs was recognized during the 1940’s in the US when the Food 
and Drug Administration, the National Institutes of Health and fourteen pharmaceutical 
manufacturers, undertook a collaborated study. This study led to the adoption of the 
procedure, which first appeared in the XII Edition of The United States Pharmacopoeia and 
was the only official test for the detection of bacterial endotoxin until the discovery of LAL. 
6.1 Limitations to the rabbit test of pyrogen (bacterial endotoxin) 
Rabbit test is limited by the elaborate nature of the test. It is expensive, time-consuming and 
subject to the variability of animal test. Rabbit test can detect endotoxin but cannot 
determine the actual concentration or endotoxin present in a solution. The Limulus 
Amebocyte Lysate (LAL) test had been described in literature as the most sensitive 
convenient method currently available for detecting bacterial endotoxin. (Bergheim, 1978) 
LAL being an in vitro test is useful in In-process detection, an important practice in In-
process quality control. This is a quantitative determination of the negative side or the limit. 
In-process material cannot be injected into rabbits since final sterilization had not been done 
on the product. An un-sterilized product portends greater risks to the animals. Hence, LAL 
has an edge over the Rabbit test of pyrogen in this regard. 
In 1973, Travenol laboratory developed its own in-house LAL test which measured the 
activated amounts of protein precipitated. In the LAL gelation reaction, samples were tested 
for the presence of protein using the Lowry protein assay and resulting differentials were 
read on spectrophotometer. This eliminates the problem of subjective reading the gel-clot 
endpoint (Bergheim, 1978).  
6.2 The Nigerian experience 
LAL in this part of the world (Nigeria) is not readily in use because the kits have to be 
imported. In the US, a laboratory will charge up to $140 per sample to run LAL test. 
There are about six LVP - manufacturing plants in Nigeria as at 2010. None of the plants 
used LAL to test for pyrogen, perhaps due to non-availability of the material locally. There 
is need to develop other in-vitro tests similar to LAL, but using extracts from animals 
readily available in the tropics. 
In an on-going research, Salawu et al., (2010) have demonstrated that delay in sterilization of 
parenteral solutions of up to 48 hrs could lead to production of highly pyrogenic solutions, 
provided the solution had been contaminated with Gram negative organism like Escherichia 
coli before the delayed sterilization. In their report the resultant increase in the population of 
the contaminating bacteria before sterilization caused an intolerable rise in pyrogen level 
even after sterilization. Such a product in real production must be discarded after the 
production cycle had been completed. This was because only sterilzed product can be 
admisnistered to rabbit for pyrogen tests.  
6.3 Investigation of endotoxin-induced protein coagulation in Archachatina marginata 
Archachatina marginata is a gasropod, found in the forest and savannah zones of West Africa. 
In Nigeria, it is a source of dietary protein, eaten in stews and soups. In traditional practice, 
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the haemolymph of the snail is applied as disinfectants to baldes and fresh cuts of 
circumscicion. This was believed to prevent sepsis of the wound and speed of healing of the 
fresh cuts of circumscision. Endotoxin–binding properties of the snail’s haemolymph 
fraction was first reported by Salawu et al. (2011). 
 
 
Fig. 12. Archachatina marginata (Source: Salawu, 2011) 
In the research, the haemolymphs of the snails were collected by the apical cracking method 
(Ogunsanmi et al., 2003). The haemolymph was mixed with anticoagulant and plasma was 
obtained by centrifugation. The pellets was washed with anticoagulant, followed by 0.1 M 
CaCl2 and the pellet containing the hemocytes (amebocytes) were homogenised and 
suspended in buffer. Exposure of the fractions from the hemocytes: hemocyte lysate (HL), 
hemocyte lysate supernatant (HLS) and hemocyte lysate debris (HLD) and the plasma were 
respectively incubated at 37°C for 1 h with endotoxin (1EU/ml) and calcium ions. Controls 
were set up with the fractions exposed to endotoxin-free water (<0.025 EU/ml) and calcium 
ions. The fraction exposed to endotoxin produced coagulates which had higher protein 
content than those exposed to endotoxin-free water. Further investigation reveaealed that 
combination of plasma and HL of the snail in various ratios produced optimal protein 
coagulation at a plasma: HL ratio of 1:1. Exposure of the mixture producing the optimal 
coagulation to varied concentrations of endotoxin ranging from 1 to 5.0 EU/ml, followed by 
incubation at 37 °C for 1h produced protein coagulation in the mixture which was linear up 
to a concentration of 1EU/ml. Further increase in endotoxin did not elicit icrease in protein 
coagulation. There was a drop in coagulation at endotoxin concentrations above 1EU/ml. 
From this study, it was concluded that the haemolymph of A. marginata contained 
endotoxin-binding proteins. It was suggested that the haemolymph may serve as a souce of 
endotoxin detection and quantification kit for testing parenteral solutions in the future 
(Salawu et al., 2011). 
The choice of Archachatina marginata was inspired by the traditional medicine practice which 
had no scientific backing. A. marginata moves by creeping on soil, wood and rock surfaces 
and produces slime from its foot which binds dirt and possibly entraps microbes found 
along its path. Such an immunological adaptation suggests a very strong defence againt 
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pathogens which was thought to be worthy of study in respect of endotoxin. This effort has 
opened more investigation and a possibility for development of ‘Archachatina Amebocyte 
Lysate’ (AAL) kit for testing endotoxin.  
This on-going research in the University of Ilorin, Nigeria, is promising in terms of having a 
tropical source of test kit for pyrogen status of parenterals and hence more affordable and 
safer, locally produced intravenuous fluids in Nigeria. A success of this research will be a 
great contributon to delivery of critical care in the developing countries, especially Nigeria. 
7. Conclusion 
Emphasis should be placed on degradation/stability studies of drugs because improper 
storage and distribution of pharmaceuticals can lead to their physical deterioration and 
chemical decomposition resulting in reduced activity and occasionally, in the formation of 
toxic degradation products.  
The increasing rate of introduction of fake and adulterated drugs into sub-saharan Africa 
countries markets makes development of alternative analytical methods a necessity due to 
lack of reagent and unavailability of equipments required in official books 
Studies of Adsorption of pharmaceuticals to excipients and additives are needed in order to 
investigate their interaction which may affect bioavailaibility of the drug. The clinical 
usefulness of these additives and excipients in the management of acute toxicity in drug 
overdose patients can be discovered from in-vitro adsorption study. 
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